| scholarly article | Q13442814 |
| P50 | author | Gianluigi Zaza | Q37635234 |
| P2093 | author name string | Francesco Paolo Schena | |
| Michele Rossini | |||
| Loreto Gesualdo | |||
| Carlo Bettocchi | |||
| Giuseppe Grandaliano | |||
| Elena Ranieri | |||
| Barbara Infante | |||
| Giovanni Stallone | |||
| Pasquale Ditonno | |||
| Antonio Schena | |||
| Paola Pontrelli | |||
| Antonia Loverre | |||
| Annamaria Maiorano | |||
| Michele Ursi | |||
| Raffaella Verrienti | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sirolimus | Q32089 |
| glomerulosclerosis | Q5571239 | ||
| P304 | page(s) | 125-134 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Rapamycin inhibits PAI-1 expression and reduces interstitial fibrosis and glomerulosclerosis in chronic allograft nephropathy | |
| P478 | volume | 85 |
| Q24339412 | A reactive oxygen species-mediated, self-perpetuating loop persistently activates platelet-derived growth factor receptor α |
| Q27000107 | A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients |
| Q92368951 | Bortezomib attenuates renal interstitial fibrosis in kidney transplantation via regulating the EMT induced by TNF-α-Smurf1-Akt-mTOR-P70S6K pathway |
| Q38668601 | Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. |
| Q37199520 | Effect of CD40 and sCD40L on renal function and survival in patients with renal artery stenosis |
| Q39060681 | Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase |
| Q37822152 | Individualizing early use of sirolimus in renal transplantation |
| Q37829386 | Is cellular senescence important in pediatric kidney disease? |
| Q43040996 | Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression |
| Q36879793 | Local application of rapamycin reduces epidural fibrosis after laminectomy via inhibiting fibroblast proliferation and prompting apoptosis |
| Q57151742 | Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation |
| Q58795433 | Rapamycin Upregulates Connective Tissue Growth Factor Expression in Hepatic Progenitor Cells Through TGF-β-Smad2 Dependent Signaling |
| Q34289498 | Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation |
| Q42679895 | Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation. |
| Q43175107 | Replacing calcineurin inhibitors with proliferation signal inhibitors after kidney transplantation: indications, results, and disadvantages |
| Q26747506 | Role of mTOR Inhibitors in Kidney Disease |
| Q38914374 | Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. |
| Q45883054 | Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury |
| Q37001941 | Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation |
| Q38866153 | Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. |
| Q39332611 | Targeted disruption of Cd40 in a genetically hypertensive rat model attenuates renal fibrosis and proteinuria, independent of blood pressure. |
| Q37066587 | The emerging role of coagulation proteases in kidney disease |
| Q37791408 | The potential benefits of rapamycin on renal function, tolerance, fibrosis, and malignancy following transplantation |
| Q38209973 | mTOR inhibitors and renal allograft: Yin and Yang. |
Search more.